TC
ABEO icon

Truvestments Capital’s Abeona Therapeutics ABEO Stock Holding History

Truvestments Capital’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.2K Hold
10,307
– – 0.01% 512
2025
Q4 		$54.3K Buy
10,307
+6,770
+191% +$34.1K 0.01% 434
2025
Q3 		$18.7K Buy
3,537
+778
+28% +$4.93K ﹤0.01% 611
2025
Q2 		$15.7K Buy
2,759
+2,708
+5,310% +$15.4K ﹤0.01% 580
2025
Q1 		$243 Hold
51
– – ﹤0.01% 986
2024
Q4 		$284 Hold
51
– – ﹤0.01% 972
2024
Q3 		$322 Buy
+51
New +$266 ﹤0.01% 889
2024
Q2 		– Sell
-51
Closed -$370 – 222
2024
Q1 		$370 Hold
51
– – ﹤0.01% 687
2023
Q4 		$256 Hold
51
– – ﹤0.01% 760
2023
Q3 		$215 Hold
51
– – ﹤0.01% 663
2023
Q2 		$206 Hold
51
– – ﹤0.01% 672
2023
Q1 		$144 Hold
51
– – ﹤0.01% 657
2022
Q4 		$157 Buy
+51
New +$191 ﹤0.01% 901
2022
Q3 		– Sell
-55
Closed – – 617
2022
Q2 		$0 Buy
+55
New +$278 ﹤0.01% 639
2022
Q1 		– Sell
-55
Closed – – 180
2021
Q4 		$0 Hold
55
– – ﹤0.01% 600
2021
Q3 		$2K Hold
55
– – ﹤0.01% 529
2021
Q2 		$2K Hold
55
– – ﹤0.01% 539
2021
Q1 		$3K Buy
55
+44
+400% +$2.42K ﹤0.01% 560
2020
Q4 		$0 Buy
+11
New +$375 ﹤0.01% 601
2020
Q3 		– Sell
-11
Closed – – 312
2020
Q2 		$0 Buy
+11
New +$760 ﹤0.01% 565
2019
Q4 		– Sell
-19
Closed -$1K – 141
2019
Q3 		$1K Sell
19
-3
-14% -$225 ﹤0.01% 676
2019
Q2 		$3K Hold
22
– – ﹤0.01% 658
2019
Q1 		$4K Buy
+22
New +$3.93K ﹤0.01% 616
2018
Q3 		$7K Buy
+22
New +$7.8K ﹤0.01% 694

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Truvestments Capital's ABEO Position: Q1 2026 in Review

Truvestments Capital held its Abeona Therapeutics (ABEO) position steady in Q1 2026 at 10,307 shares worth $46.2K. The position accounts for 0.01% of the portfolio, ranked #512.

Truvestments Capital first reported a position in ABEO in Q3 2018 and has held it in 24 quarters since. The position peaked at $54.3K in Q4 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Truvestments Capital held 10,307 shares of Abeona Therapeutics worth $46.2K as of Q1 2026.
  • Truvestments Capital left its Abeona Therapeutics share count unchanged in Q1 2026.
  • Abeona Therapeutics made up 0.01% of Truvestments Capital's portfolio in Q1 2026, its #512 holding.
  • Truvestments Capital first reported a position in Abeona Therapeutics in Q3 2018 and has held it in 24 quarters since.
  • Truvestments Capital's Abeona Therapeutics position peaked at $54.3K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.